493800 Sigma-AldrichPARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem
The PARP Inhibitor VI, NU1025, also referenced under CAS 90417-38-2, controls the biological activity of PARP. This small molecule/inhibitor is primarily used for Cell Structure applications.
More>> The PARP Inhibitor VI, NU1025, also referenced under CAS 90417-38-2, controls the biological activity of PARP. This small molecule/inhibitor is primarily used for Cell Structure applications. Less<<Synonyms: 8-Hydroxy-2-methylquinazoline-4-one
Recommended Products
Przegląd
Replacement Information |
---|
Tabela kluczowych gatunków
CAS # | Empirical Formula |
---|---|
90417-38-2 | C₉H₈N₂O₂ |
Products
Numer katalogowy | Opakowanie | Ilość/opak. | |
---|---|---|---|
493800-5MG | Ampulka plastikowa | 5 mg |
Product Information | |
---|---|
CAS number | 90417-38-2 |
ATP Competitive | N |
Form | Off-white solid |
Hill Formula | C₉H₈N₂O₂ |
Chemical formula | C₉H₈N₂O₂ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | PARP |
Primary Target IC<sub>50</sub> | 0.4 µM against poly(ADP-ribose) polymerase (PARP) |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information | |
---|---|
Packaged under inert gas | Packaged under inert gas |
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Numer katalogowy | GTIN |
493800-5MG | 04055977272826 |
Documentation
PARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem MSDS
Title |
---|
PARP Inhibitor VI, NU1025 - CAS 90417-38-2 - Calbiochem Certificates of Analysis
Title | Lot Number |
---|---|
493800 |
References
Przegląd literatury |
---|
Delaney, C.A., et al. 2000. Clin. Cancer Res. 6, 2860. Boulton, S., et al. 1999. Carcinogenesis 20, 199. Bowman, K.J., et al. 1998. Br. J. Cancer 78, 1269. Griffin, R.J., et al. 1998. J. Med. Chem. 41, 5247. Griffin, R.J., et al. 1996. Pharm. Sci. 2, 43. Boulton, S., et al. 1995. Br. J. Cancer 72, 849. Griffin, R.J., et al. 1995. Anticancer Drug Res. 10, 507. |